Related Experiment Video
Updated: Jun 17, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
[Exosomes derived form bladder transitional cell carcinoma cells induce CTL cytotoxicity in vitro]
Jia-mo Zhang1, Xiao-hou Wu, Yao Zhang
1Department of Urology, First Hospital, Chongqing Medical University, Chongqing 400016, China.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|December 22, 2009
Summary
Human bladder cancer T24 cell-derived exosomes, containing HSP70 and ICAM-1, effectively induce cytotoxic T lymphocytes (CTLs) with significant antitumor activity in vitro.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Context:
- Bladder transitional cell carcinoma (T24) poses a significant health challenge.
- Exosomes are emerging as critical mediators in intercellular communication and cancer progression.
- Understanding exosome composition and function is key to developing novel cancer therapies.
Purpose:
- To isolate and characterize exosomes from T24 bladder cancer cells.
- To investigate the immunomodulatory potential of these exosomes.
- To evaluate the efficacy of exosome-pulsed dendritic cells in inducing anti-tumor cytotoxic T lymphocytes (CTLs).
Summary:
- Exosomes isolated from T24 cells were characterized as 30-90 nm vesicles containing immunoproteins HSP70 and ICAM-1.
- Dendritic cells pulsed with these exosomes were co-cultured with T cells.
- The resulting CTLs demonstrated significant cytolytic activity against tumor cells.
Impact:
- This study demonstrates that T24 cell-derived exosomes can be utilized to stimulate an anti-tumor immune response.
- Exosomes loaded with specific immunoproteins hold promise for cancer immunotherapy development.
- These findings contribute to the growing field of exosome-based cancer therapeutics.
